Dublin, Nov. 18, 2016 -- Research and Markets has announced the addition of the "Cell Expansion Global Market - Forecast to 2022" report to their offering.
The cell expansion market is expected to grow at a double digit CAGR to reach $23,997 million by 2022
Among the cell expansion products, the consumables dominated the market by occupying a largest share and instruments market is estimated to be the fastest growing segment from 2015 to 2022. In cell types, human cell types is the largest segment as well as the fastest growing segment. In applications, the regenerative medicine and stem cell research is the largest segment and is the fastest growing segment with a highest CAGR of 18.1% from 2015-2022. By end- users, hospitals and bio banks are the largest segment with a share of 37.0% and also, the fastest segment from 2015 to 2022.
Rising prevalence of chronic diseases, increasing government funding for research, increased investments in cell based products, growing number of GMP-certified production facilities and 3D cell expansion technology are some of the drivers in the cell expansion global market. High cost of cell-based research, use of unregulated products, quality issues for end users, ethical concerns regarding research on cell biology and stringent regulation are some of the factors hampering the market.
The cell expansion global market is a highly competitive market and all the existing players in this market are involved in developing new and advanced products to maintain their market shares.
Some of the key players of the cell expansion market are
- Becton Dickinson and Company (U.S.)
- Corning, Inc. (U.S.)
- Danaher Corporation (U.S.)
- Eppendorf AG (Germany)
- GE Healthcare (U.K)
- Lonza Group Ltd. (Switzerland)
- Merck KGAA (Germany.)
- Miltenyi Biotec (Germany)
- STEMCELL Technologies (Canada)
- Terumo Corporation (Japan)
- ThermoFisher Scientific Inc. (U.S.)
Key Topics Covered:
1 Executive Summary
2 Introduction
3 Market Analysis
3.1 Introduction
3.2 Market Segmentation
3.3 Factors Influencing Market
3.3.1 Drivers And Opportunities
3.3.1.1 Rising Prevalence Of Chronic Diseases
3.3.1.2 Increasing Government Funding For Research
3.3.1.3 Increased Investments In Cell Based Research
3.3.1.4 Growing Number Of Gmp-Certified Production Facilities.
3.3.1.5 3D Cell Expansion Technology
3.3.1.6 Countries In Asia-Pacific Region To Present High-Growth Opportunities
3.3.2 Restraints And Threats
3.3.2.1 High Cost Of Cell-Based Products
3.3.2.2 Use Of Unregulated Products
3.3.2.3 Quality Issues For End Users
3.3.2.4 Ethical Concerns Regarding Research On Cell Biology
3.3.2.5 Stringent Regulation
3.4 Porter's Five Force Analysis
3.5 Regulatory Guidelines
3.6 Upcoming Technologies
3.7 Supply Chain Analysis
3.8 Market Share Analysis By Major Players
3.9 Patent Trends
4 Cell Expansion Global Market, By Products
4.1 Introduction
4.2 Instruments
4.2.1 Cell Expansion Supporting Equipments
4.2.1.1 Flow Cytometers
4.2.1.2 Centrifuge
4.2.1.3 Cell Counters
4.2.1.4 Other Cell Expansion Supporting Equipments
4.2.2 Bioreactors
4.2.2.1 Stirred Type Bioreactors
4.2.2.2 Microcarrier-Based Anchorage-Dependent Stirred Type Bioreactors
4.2.2.3 Suspension-Based Anchorage Independent Stirred Type Bioreactors
4.2.2.4 Hollow Fiber/Perfusion Bioreactors
4.2.2.5 Bubble Column And Airlift Bioreactors
4.2.2.6 Single Use/Disposabable Bioreactors
4.2.2.7 Other Bioreactors
4.2.3 Automated Cell Expansion Systems
4.3 Consumables
4.3.1 Reagents, Media And Sera
4.3.2 Disposables
4.3.2.1 Culture Vessels
4.3.2.2 Bioreactor Accessories
4.3.2.3 Others
5 Cell Expansion Market, By Types
5.1 Introduction
5.2 Animal Cell
5.3 Human Cell
5.3.1 Adult Stem Cell
5.3.1.1 Neural Stem Cells (NSCS)
5.3.1.2 Hematopoietic Stem Cells (HSCS)
5.3.1.3 Mesenchymal Stem Cells (MSC)
5.3.2 Induced Pluripotent Stem Cell (IPSC)
5.3.3 Embryonic Stem Cell
5.4 Bacterial Cells
5.5 Others
6 Cell Expansion Global Market, By Applications
6.1 Introduction
6.2 Regenerative Medicine And Stem Cell Research
6.3 Cancer Studies
6.4 Others
7 Cell Expansion Global Market, By End Users
7.1 Introduction
7.2 Academic And Research Institutes
7.3 Biotechnology And Biopharmaceutical Company
7.4 Hospitals And Bio Banks
7.5 Others
8 Regional Market Analysis
9 Company Developments
9.1 Introduction
9.2 New Product Launch
9.3 Agreements Parterner Ships, Collaborations & Joint Ventures
9.4 Other Developments
9.5 Merger And Acqisition
10 Company Profiles
Companies Featured:
- 300Microns Gmbh
- Abec Inc
- Acea Bioscience, Inc
- Alere Inc
- Antigen America Inc.
- Applikon Biotechnologies
- Auxilab S.L
- Axol Bioscience
- Bbi Biotec
- Becton, Dickinson And Company
- Biological Industry
- Biomerieux
- Bioreactor Sciences
- Cell Applications, Inc.
- Cellgenix
- Celltreat Scientific Products
- Celprogen Inc
- Chemometec Usa Inc
- Cole Parmer
- Corning, Inc.
- Danaher Corporation
- Diagenode S.A
- Eppendorf AG
- Fineesse
- Flownamics
- GE Healthcare
- Genlantis
- Haier
- Handyem
- Hettich Lab Technology
- Hi-Media
- Hitachi
- Hurel Corporation
- IBA
- Infors HT
- Inoxcva
- Leica Biosystems
- Logos Biosystems
- Lonza Group Ltd.
- Memmert Gmbh
- Merck KGAA
- Miltenyi Biotec
- Molecular Devices
- Olympus Corporation
- Pall Corporation
- PBS Biotech
- Percell Biolytica AB
- Prodizen, Inc.
- R&D Systems
- Reachbio Llc
- Reinnervate
- Roosterbio
- RR Mechetronics
- Sartorious AG
- Stembiosys
- Stemcell Technologies
- Sunrise Science Products, Inc.
- Synthecon
- Sysmex
- Takara Bio
- Terumo Corporation
- Thermo Fisher Scientific
- Toyo Gosei Co., Ltd
- Vision Scientific Co Ltd
- Vivo Biosciences Inc.
- Zen-Bio Inc
For more information about this report visit http://www.researchandmarkets.com/research/6nwnwp/cell_expansion
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Biotechnology


Winter Storm Devin Triggers Massive Flight Cancellations and Travel Disruptions Across the U.S.
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Nvidia and Groq Strike Strategic AI Inference Licensing Deal
Nvidia to Acquire Groq in $20 Billion Deal to Boost AI Chip Dominance
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
L&F Tesla Battery Supply Deal Value Drops Sharply Amid EV Market Slowdown
Lloyds Banking Group to Close Invoice Factoring Business by End of 2025
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Star Entertainment Leadership Shake-Up Deepens as CFO and COO Exit Amid Ongoing Restructuring
Vietnam’s EV Taxi Giant GSM Eyes Hong Kong IPO With $2–3 Billion Valuation
Applied Digital Stock Rises on AI Cloud Spinoff Plan and ChronoScale Launch
Trump Administration Probes Corporate DEI Programs, Raising Questions for Google Stock
Winter Storm Disrupts Northeast Travel as Snow and Ice Blanket New York, New Jersey
China’s LandSpace Takes Aim at SpaceX With Reusable Rocket Ambitions
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
BP’s Castrol Stake Sale Raises Debt Relief Hopes but Sparks Cash Flow Concerns 



